XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 60 filers reported holding XENON PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,716,643 | -29.9% | 167,349 | -21.0% | 0.00% | -50.0% |
| Q2 2023 | $8,152,031 | +14.2% | 211,741 | +6.2% | 0.00% | 0.0% |
| Q1 2023 | $7,136,061 | -53.4% | 199,387 | -48.7% | 0.00% | -33.3% |
| Q4 2022 | $15,313,035 | -3.1% | 388,360 | -11.3% | 0.00% | -25.0% |
| Q3 2022 | $15,799,000 | -7.8% | 437,645 | -22.3% | 0.00% | 0.0% |
| Q2 2022 | $17,132,000 | -3.2% | 563,187 | -2.8% | 0.00% | +33.3% |
| Q1 2022 | $17,707,000 | -28.4% | 579,208 | -26.8% | 0.00% | -25.0% |
| Q4 2021 | $24,727,000 | +73.1% | 791,525 | -15.3% | 0.00% | +33.3% |
| Q3 2021 | $14,282,000 | -18.0% | 934,643 | -0.1% | 0.00% | 0.0% |
| Q2 2021 | $17,420,000 | +1.6% | 935,542 | -2.4% | 0.00% | -25.0% |
| Q1 2021 | $17,152,000 | +17.5% | 958,153 | +0.9% | 0.00% | +33.3% |
| Q4 2020 | $14,599,000 | +76.6% | 949,238 | +27.1% | 0.00% | +50.0% |
| Q3 2020 | $8,267,000 | -17.0% | 746,803 | -6.0% | 0.00% | -33.3% |
| Q2 2020 | $9,966,000 | +30.0% | 794,689 | +17.6% | 0.00% | 0.0% |
| Q1 2020 | $7,664,000 | +137.4% | 675,876 | +174.5% | 0.00% | +200.0% |
| Q4 2019 | $3,228,000 | +43.1% | 246,263 | -1.6% | 0.00% | 0.0% |
| Q3 2019 | $2,255,000 | +0.5% | 250,250 | +10.0% | 0.00% | 0.0% |
| Q2 2019 | $2,244,000 | – | 227,539 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 266,961 | $10,277,999 | 12.45% |
| COMMODORE CAPITAL LP | 1,845,000 | $71,032,500 | 7.98% |
| Altium Capital Management LP | 228,000 | $8,778,000 | 6.64% |
| TLS Advisors LLC | 33,756 | $1,300 | 5.58% |
| GREAT POINT PARTNERS LLC | 530,000 | $20,405,000 | 3.99% |
| DAFNA Capital Management LLC | 280,538 | $10,800,713 | 2.95% |
| Paradigm Biocapital Advisors LP | 989,327 | $38,089,090 | 2.94% |
| Nan Fung Group Holdings Ltd | 114,380 | $4,403,630 | 2.81% |
| Avoro Capital Advisors LLC | 4,900,000 | $188,650,000 | 2.56% |
| Ghost Tree Capital, LLC | 185,000 | $7,122,500 | 2.35% |